We are a research consortium Assessing Tools to Predict and Stage Dementia. Our clinical study incorporates genetic testing, digital, cognitive-functional testing, wearable device data, medical record analysis, and biofluid analysis. Our team has already identified proteogenomic biomarkers that are novel in accurately predicting and Late Onset Alzheimer's Disease 10 years before symptoms develop . We will follow up on our initial 2-year proof of performance study that with all types of adult dementia. Funding from this GoFundMe will provide indirect cost support and additional direct cost support for our IRB approved clinical protocol.